Particle.news
Download on the App Store

Patient Square Capital to Take Premier Private in $2.6 Billion All-Cash Deal

The deal targets early 2026 closing subject to shareholder and regulatory approvals.

Overview

  • Premier stockholders will receive $28.25 in cash per share, a 23.8% premium to the 60‑day volume‑weighted average price as of September 5, 2025.
  • Premier’s board unanimously approved the agreement, and the transaction is not contingent on financing.
  • Upon completion, Premier will be delisted and will suspend future common stock dividends after paying a $0.21 dividend on September 15.
  • Executives from Premier and Patient Square cited plans to accelerate investment in supply chain services, data, technology, and advisory offerings under private ownership.
  • PINC shares traded higher in premarket action following the announcement, with one report citing an 8.5% gain to $27.95.